Mechanical Thrombectomy Devices Market to Reach USD 5.9 Billion by 2036, Fueled by Rising Stroke Burden and Minimally Invasive Clot Removal

The global mechanical thrombectomy devices market is expanding rapidly as healthcare systems increasingly adopt minimally invasive technologies for the treatment of acute ischemic stroke and other thromboembolic conditions. The market was valued at USD 2.1 billion in 2025 and is projected to reach USD 5.9 billion by 2036, advancing at a CAGR of 10.9% from 2026 to 2036.

Growing incidence of ischemic stroke, deep vein thrombosis, pulmonary embolism, and peripheral vascular disease is increasing demand for rapid clot-removal technologies. At the same time, improved clinical evidence, expanding stroke-center infrastructure, better imaging capabilities, and continuous innovation in stent retrievers and aspiration systems are accelerating adoption.

The market is also benefiting from efforts to expand thrombectomy access beyond major comprehensive stroke centers into primary and regional hospitals. Faster device delivery, improved navigation, and physician training are becoming increasingly important as healthcare providers focus on reducing treatment delays and improving outcomes.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85906

Rising Stroke Burden Drives Mechanical Thrombectomy Adoption

The growing global burden of stroke represents one of the strongest growth drivers for the mechanical thrombectomy devices industry.

Acute ischemic stroke occurs when a blood clot blocks blood flow to part of the brain. For appropriately selected patients, mechanical thrombectomy can physically remove the clot and restore circulation, making rapid intervention an important component of modern stroke care.

According to CDC data cited in the market analysis, approximately 7.8 million U.S. adults have experienced a stroke during their lifetime, while more than 795,000 Americans experience a stroke each year. Ischemic strokes account for approximately 87% of strokes in the United States.

The resulting need for rapid intervention is increasing demand for stent retrievers, aspiration catheters, guide catheters, balloon guide catheters, and other clot-removal systems.

Expansion of comprehensive stroke centers and improvements in emergency stroke workflows are also allowing more eligible patients to access endovascular treatment.

Device Innovation and Regulatory Clearances Strengthen Market Growth

Continuous technological development is improving the efficiency, navigability, and safety of thrombectomy procedures.

Manufacturers are developing next-generation devices capable of reaching complex vascular anatomy while improving clot engagement and reducing vessel trauma. Innovations include improved stent designs, large-bore aspiration catheters, combined aspiration-and-retrieval approaches, advanced delivery systems, and increasingly flexible navigation technologies.

A major focus is reducing procedure time. Since neurological outcomes can depend heavily on how quickly blood flow is restored, devices that simplify deployment and accelerate clot removal can provide important clinical and operational benefits.

Regulatory clearances are also expanding the range of commercially available technologies. In January 2026, the RoVo Mechanical Thrombectomy System received an FDA 510(k) substantial-equivalence determination, supporting continued development and competition within the thrombectomy device landscape.

As clinical adoption expands, manufacturers are expected to emphasize usability, procedural efficiency, compatibility with existing catheterization infrastructure, and improved performance across different clot types and anatomical conditions.

Expansion of Thrombectomy Access Creates Major Opportunity

One of the most significant opportunities lies in expanding mechanical thrombectomy services from major comprehensive stroke centers to primary stroke centers and regional hospitals.

Time is a critical factor in treating large-vessel-occlusion stroke. Patients initially transported to hospitals without neurointerventional capabilities may require transfer to another facility, potentially increasing the time before treatment.

This creates an opportunity for manufacturers to develop devices that are:

• Faster to deploy
• Easier to navigate
• Compatible with broader hospital workflows
• Effective across different vascular anatomies
• Designed to simplify physician training

Expansion of stroke networks and greater coordination between emergency departments, imaging centers, ambulance services, and neurointerventional facilities can further support market development.

Companies that combine device innovation with physician education, simulation-based training, hospital partnerships, and stroke-network collaborations may be well positioned to capture this opportunity.

Stent Retrievers Remain the Leading Component Segment

Stent retrievers accounted for approximately 47% of the mechanical thrombectomy devices market in 2025, making them the leading component segment.

Stent retrievers are designed to engage and capture clots within blocked blood vessels so they can be removed and blood flow restored. Their established role in acute ischemic stroke treatment and widespread adoption among neurointerventional specialists have supported their market leadership.

Technological improvements are focused on increasing clot engagement, improving navigability through tortuous vessels, and reducing the risk of vessel injury.

The segment is also benefiting from greater awareness of the importance of rapid stroke intervention and increasing investment in specialized stroke-care facilities.

Although aspiration-based systems continue to gain adoption and combined approaches are becoming increasingly important, stent retrievers are expected to maintain a strong position throughout the forecast period.

→Explore Strategies & Trends - Request Full Report Access – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85906

Neurovascular Thrombectomy Represents a Core Application

Mechanical thrombectomy has become particularly important in neurovascular intervention, where rapid removal of a clot can restore blood flow to brain tissue in appropriately selected ischemic-stroke patients.

The increasing availability of advanced CT and angiographic imaging is helping physicians identify eligible patients and plan interventions more effectively.

At the same time, peripheral vascular thrombectomy is expanding as healthcare providers address venous thromboembolism and other vascular conditions. The growing use of aspiration-based technologies in peripheral arteries and veins is encouraging companies to diversify their thrombectomy portfolios.

This broadening of applications provides manufacturers with opportunities beyond traditional neurovascular procedures.

North America Leads the Global Market

North America dominated the mechanical thrombectomy devices market in 2025, accounting for approximately 45% of global revenue.

The region benefits from advanced healthcare infrastructure, high awareness of stroke symptoms, established comprehensive stroke centers, sophisticated medical imaging capabilities, and the presence of leading neurovascular device manufacturers.

The United States remains particularly important because of its large patient population, extensive network of specialized stroke facilities, and established ecosystem for minimally invasive vascular procedures.

Physician training and improvements in emergency stroke-care networks are also supporting higher procedure volumes. Increasing emphasis on reducing stroke-related mortality and long-term disability is encouraging healthcare providers to adopt technologies capable of restoring blood flow rapidly.

Canada is also expected to contribute to regional growth as access to advanced neurovascular intervention expands.

Europe is another significant market, while Asia Pacific and other emerging regions offer considerable long-term potential as healthcare infrastructure, stroke awareness, specialist availability, and access to advanced imaging improve.

Competitive Landscape

The global mechanical thrombectomy devices market is highly competitive and includes major medical-device companies with expertise in neurovascular and peripheral vascular intervention.

Key participants include Medtronic, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, Abbott, Becton, Dickinson & Company (BD), and Koninklijke Philips N.V.

Companies are pursuing growth through:

• Product innovation
• Expansion of neurovascular portfolios
• Peripheral vascular applications
• Acquisitions and strategic partnerships
• Physician education and training
• International distribution expansion
• Development of faster and more navigable thrombectomy systems

The competitive environment is increasingly influenced by the ability to provide complete procedural solutions rather than individual devices alone.

Major Industry Developments

The market has witnessed several significant strategic and product developments.

In January 2026, Boston Scientific announced an agreement to acquire Penumbra, Inc., a company known for neurovascular and thrombectomy technologies. The transaction is intended to expand Boston Scientific's cardiovascular portfolio and strengthen its presence in mechanical thrombectomy and neurovascular intervention.

In December 2025, Medtronic announced the first commercial use of its Liberant Thrombectomy System, expanding the company's peripheral arterial and venous disease portfolio into mechanical aspiration thrombectomy. The first procedure was performed at Mount Sinai Hospital in New York in November 2025.

In February 2025, Stryker completed its acquisition of Inari Medical, strengthening its position in the peripheral vascular market. Inari's technologies focus on clot removal for venous thromboembolism, complementing Stryker's existing medical-device portfolio.

These developments highlight the industry's broader movement toward consolidation and diversification across both neurovascular and peripheral vascular thrombectomy.

Future Outlook

The global mechanical thrombectomy devices market is expected to grow from USD 2.1 billion in 2025 to USD 5.9 billion by 2036, representing a 10.9% CAGR.

The combination of a rising stroke burden, growing adoption of minimally invasive interventions, technological innovation, improved imaging, and expansion of specialized stroke-care infrastructure is expected to sustain strong market growth.

Stent retrievers, with their established clinical role and approximately 47% market share, are expected to remain a leading component. Meanwhile, aspiration catheters and combination thrombectomy approaches are likely to gain further traction as manufacturers seek to improve procedural efficiency.

North America is expected to maintain its market leadership, while developing markets present significant opportunities through expansion of thrombectomy-capable hospitals and improved access to neurointerventional specialists.

Overall, the market is moving toward faster, more navigable, easier-to-use, and increasingly versatile clot-removal systems, with the expansion of thrombectomy access emerging as one of the most important opportunities through 2036.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=85906<ype=S

→Explore Latest Research Reports by Transparency Market Research:

Asthma Spacers Market

Intragastric Balloons Market

Gynecological Devices Market

Ultrasound Devices Market

Portable Oxygen Concentrators Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com